19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Medications
Resources
Basic InformationLatest News
Are 'Inactive' Ingredients in Your Drugs Really So Harmless?Which Misused Prescription Meds Send Americans to the ER?Health Tip: What You Should Know About AntibioticsWhite House Plan to Disclose Drug Prices May Not Drive Down Costs: StudyWhen Your Medications Are the News1 in 4 Antibiotic Prescriptions Isn't Needed: StudyDermatologists Cut Back on Antibiotics But Still Prescribe the MostEven Older Drugs Are Getting Steep Price Hikes, Study FindsNew Cholesterol Drug's High Price May Not Be Worth It: StudyAre You Overdoing Antibiotics?Health Tip: Safe Tips For Antibiotic UseDrug Studies in Children Often Go Unfinished: StudyAmerica Is Worried About Antibiotic ResistanceMany U.S. Parents Share Leftover Antibiotics: SurveyFirst U.S. Drug Containing Marijuana-Derived Ingredient Goes on SaleGot Unused Prescription Meds? Saturday Is National Drug Take-Back DayAre Generics as Good as Brand-Name Drugs?White House Wants Prices in Drug Ads, But Big Pharma Fights BackHalf of Antibiotics Given Without Infection DiagnosisDoes Big Pharma Hike Prices When Meds Are in Short Supply?Timing May Be Critical When Taking MedsSurprising Tactic in War Against Antibiotic ResistanceOpium Poppy Genome Research May Aid Painkiller ProductionAs U.S. Kids Take More Meds, Dangerous Drug Mixes Could RiseHealth Tip: Grapefruit May Interact With MedicationFDA Slaps Stronger Warnings on Potent Class of AntibioticsTesting for Penicillin Allergy May Cut 'Superbug' Infection RiskAre Your Meds Making You Depressed?Nonprofit Manufacturer Could Keep Generic Drug Costs DownHealth Tip: Manage Your Daily MedicationUnused Meds? Saturday Is National Drug Take Back DayNonoptimized Drug Therapy Costs More Than $500 Billion AnnuallyIt Costs $2.2 Billion a Year to Treat Antibiotic ResistanceCDC: Aggressive Action Needed to Contain Antibiotic ResistanceER Docs Prescribe More Opioids Than They RealizeGlobal Antibiotic Use Soars as Resistance Fears RiseHealth Tip: Packing Prescriptions for Travel
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

Nonprofit Manufacturer Could Keep Generic Drug Costs Down


HealthDay News
Updated: May 16th 2018

new article illustration

WEDNESDAY, May 16, 2018 (HealthDay News) -- A nonprofit manufacturer could help keep generic drug prices down and maintain their supply, according to a perspective piece published in the May 17 issue of the New England Journal of Medicine.

Dan Liljenquist, J.D., from Intermountain Healthcare in Salt Lake City, and colleagues discuss generic drug market failure, whereby a generic drug manufacturer increases the drug price, which can compromise care.

The authors note that other manufacturers do not enter the seemingly lucrative generic drug market partly because of the initial investment required and cost of obtaining U.S. Food and Drug Administration approval. In addition, there is concern that once a second drug is approved for the condition, the manufacturer of the original generic will reduce the price of its product. One solution is establishment of a nonprofit generic drug manufacturer with the aim of producing affordable versions of essential drugs and ensuring a stable supply. A consortium of hospitals and health plans is currently developing a nonprofit generic drug manufacturer named Project Rx. The nonprofit manufacturer, which has a legal constraint that it cannot distribute earnings, will pursue a cost-plus strategy, generating enough revenue to cover costs and maintain a limited surplus for financial viability rather than profit maximization.

"We believe that Project Rx may drive other nonprofit and for-profit manufacturers to enter generic-drug markets, compete among themselves, and collectively improve market efficiency and broaden access to generic drugs," the authors write.

One author disclosed serving as a volunteer on the advisory committee of Project Rx.

Abstract/Full Text